Movatterモバイル変換

[0]ホーム
URL:

FR2306684A1 - Immunostimulant compsns. contg. propylene glycol and glycerol - a surfactant, a preservative, a buffer and water - Google Patents

Immunostimulant compsns. contg. propylene glycol and glycerol - a surfactant, a preservative, a buffer and water

Info

Publication number
FR2306684A1
FR2306684A1FR7511437AFR7511437AFR2306684A1FR 2306684 A1FR2306684 A1FR 2306684A1FR 7511437 AFR7511437 AFR 7511437AFR 7511437 AFR7511437 AFR 7511437AFR 2306684 A1FR2306684 A1FR 2306684A1
Authority
FR
France
Prior art keywords
glycerol
preservative
water
propylene glycol
compsns
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7511437A
Other languages
French (fr)
Other versions
FR2306684B1 (en
Inventor
Mario-Louis Renoux
Guy De Montis
Alain Roche
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CRINEX LAB
Original Assignee
CRINEX LAB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CRINEX LABfiledCriticalCRINEX LAB
Priority to FR7511437ApriorityCriticalpatent/FR2306684A1/en
Publication of FR2306684A1publicationCriticalpatent/FR2306684A1/en
Application grantedgrantedCritical
Publication of FR2306684B1publicationCriticalpatent/FR2306684B1/fr
Grantedlegal-statusCriticalCurrent

Links

Classifications

Landscapes

Abstract

The title compsns. are new and opt. contain vitamin A and/or vitamin E. They may also contain antigens. A typical compsn. contains glycerol 30 g., propylene glycol 9.83 g., 'Tween 80' (RTM) 6.66 g., sorbic acid 0.18 g. vitamin A 0.33 g., Na3PO4/citrate buffer to pH 5, and water to 100 ml. Pref. ranges are 7.5-15% w/v of glycol, 30% w/v of glycerol, 5-15% w/v of polyoxyethylated fatty acids as surfactants, buffers to pH 4.5-6.5, a preservative such as sorbic acid, propyl gallate or lauryl gallate.
FR7511437A1975-04-111975-04-11Immunostimulant compsns. contg. propylene glycol and glycerol - a surfactant, a preservative, a buffer and waterGrantedFR2306684A1 (en)

Priority Applications (1)

Application NumberPriority DateFiling DateTitle
FR7511437AFR2306684A1 (en)1975-04-111975-04-11Immunostimulant compsns. contg. propylene glycol and glycerol - a surfactant, a preservative, a buffer and water

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
FR7511437AFR2306684A1 (en)1975-04-111975-04-11Immunostimulant compsns. contg. propylene glycol and glycerol - a surfactant, a preservative, a buffer and water

Publications (2)

Publication NumberPublication Date
FR2306684A1true FR2306684A1 (en)1976-11-05
FR2306684B1 FR2306684B1 (en)1980-02-08

Family

ID=9153846

Family Applications (1)

Application NumberTitlePriority DateFiling Date
FR7511437AGrantedFR2306684A1 (en)1975-04-111975-04-11Immunostimulant compsns. contg. propylene glycol and glycerol - a surfactant, a preservative, a buffer and water

Country Status (1)

CountryLink
FR (1)FR2306684A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
EP0222835A4 (en)*1985-05-151988-02-01Biotech Australia Pty Ltd ORAL Vaccines.
EP0572190A1 (en)*1992-05-261993-12-01Santen Pharmaceutical Co., Ltd.Ophthalmic compositions containing vitamin E or ester thereof as an active ingredient
US6103243A (en)*1985-05-152000-08-15Biotechnology Australia Pty, LtdOral vaccines
WO2000056361A3 (en)*1999-03-242001-03-01Secr DefenceVaccine composition

Cited By (7)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
EP0222835A4 (en)*1985-05-151988-02-01Biotech Australia Pty Ltd ORAL Vaccines.
US6103243A (en)*1985-05-152000-08-15Biotechnology Australia Pty, LtdOral vaccines
EP0572190A1 (en)*1992-05-261993-12-01Santen Pharmaceutical Co., Ltd.Ophthalmic compositions containing vitamin E or ester thereof as an active ingredient
US5559157A (en)*1992-05-261996-09-24Santen Pharmaceutical Co., Ltd.Ophthalmic compositions containing vitamin E or ester thereof as an active ingredient
CN1053807C (en)*1992-05-262000-06-28参天制药株式会社Vitamin E drop
WO2000056361A3 (en)*1999-03-242001-03-01Secr DefenceVaccine composition
AU762078B2 (en)*1999-03-242003-06-19Secretary Of State For Defence, TheVaccine composition

Also Published As

Publication numberPublication date
FR2306684B1 (en)1980-02-08

Similar Documents

PublicationPublication DateTitle
IE830114L (en)Propylene glycol diester solutions of pge-type compounds
SE8405929D0 (en) PHARMACEUTICAL COMPOSITION
ES502647A0 (en) A PROCEDURE FOR THE PREPARATION OF AN INJECTABLE RAPAMICINE COMPOSITION
ES2052645T3 (en) POLYINSATURATED ACIDS WITH VASOCINETIC ACTION AND PHARMACEUTICAL AND COSMETIC FORMULATIONS THAT CONTAIN THEM.
FR2452485B1 (en) NOVEL 4-AMINO-3-QUINOLEINECARBOXYLIC ACIDS AND ESTERS, ESPECIALLY USEFUL AS ANTISECRETORY AND ANTI-ULCER AGENTS
IT7920106A0 (en) PROCEDURE FOR THE PREPARATION OF CONCENTRATED DYE SOLUTIONS AND CONCENTRATED WHITENING AGENTS SOLUTIONS.
MX9205313A (en) PHARMACEUTICAL COMPOSITION INCLUDING A SALT FORMED BY RANITIDINE AND A BISMUTE COMPLEX WITH A CARBOXYLIC ACID, WITH ANTIBIOTICS AND METHOD TO PREPARE THE SAME
IT1208480B (en) AGENT TO INTENSIFY THE ANTITUMORAL ACTION OF AN ANTI-CANCER AGENT.
FR2306684A1 (en)Immunostimulant compsns. contg. propylene glycol and glycerol - a surfactant, a preservative, a buffer and water
ES512583A0 (en) "PROCEDURE TO IMPROVE THE AMPLIFICATION AND EXPRESSION OF HYBRID VECTORS".
JPS5218609A (en)Structure of vibration-prof track
JPS5218610A (en)Structure of vibration-proof track
JPS5764609A (en)Cyclophosphamide composition for rectal administration
JPS5244357A (en)Manufacturing method for a plastic retainer for a sliding bearing
ATE2871T1 (en) PREPARATION TO COMBAT SUCTION MASTITIS AND PYOGENES MASTITIS IN BOVINE.
JPS5419652A (en)Lead bonding method
JPS5270084A (en)Polysaccharide ax
JPS5250442A (en)Magnetic coupling
JPS527882A (en)Water repellent, oil repellent agents
SE8304331D0 (en) PHARMACEUTICAL WITH ANALGETIC EFFECT
IT1209617B (en) PROCEDURE FOR THE PREPARATION OF ALCHYLARYLETERS.
JPS52133455A (en)Mechanical power break and make system
FR2067584A6 (en)Acetal compsns as non-ionic surfactants
JPS51139806A (en)Preparation of wool alcohols and wool fatty acids
JPS51143483A (en)Method of deoxidizing disposal of foods and to preserve the same

Legal Events

DateCodeTitleDescription
STNotification of lapse
[8]ページ先頭
©2009-2025 Movatter.jp